Male sexual dysfunction
(UMLS:C1112443)
- UMLS ID:
- C1112443
- MeSH ID:
- N/A
Synonym(s)
1.
Male sexual dysfunction
2.
Unspecified male sexual dysfunction
3.
dysfunction male sexual
4.
dysfunctions male sexual
5.
male sexual dysfunction
6.
sexual dysfunction male
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Finasteride | FAERS: 51 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Sertraline | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 3 | Fluoxetine | FAERS: 5 | US FAERS | |
| 4 | Sertraline | FAERS: 5 | US FAERS | |
| 5 | Desvenlafaxine Succinate | FAERS: 4 | US FAERS | |
| 6 | Rosiglitazone | FAERS: 4 | US FAERS | |
| 7 | Aripiprazole | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Citalopram | FAERS: 3 | US FAERS | |
| 9 | Isotretinoin | FAERS: 3 | US FAERS | |
| 10 | Atomoxetine Hydrochloride | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Citalopram | FAERS: 2 | US FAERS | |
| 12 | Dutasteride | FAERS: 2 | OFFSIDES SIDER US FAERS | |
| 13 | Fluoxetine | FAERS: 2 | US FAERS | |
| 14 | Goserelin | FAERS: 2 | US FAERS | |
| 15 | Levofloxacin | FAERS: 2 | US FAERS | |
| 16 | Paroxetine | FAERS: 2 | SIDER US FAERS | |
| 17 | Perindopril | FAERS: 2 | SIDER US FAERS | |
| 18 | Quetiapine Fumarate | FAERS: 2 | US FAERS | |
| 19 | Rosiglitazone | FAERS: 2 | US FAERS | |
| 20 | Rosuvastatin Calcium | FAERS: 2 | US FAERS | |
| 21 | Testosterone | FAERS: 2 | US FAERS | |
| 22 | pomalidomide | FAERS: 2 | US FAERS | |
| 23 | valdecoxib | FAERS: 2 | OFFSIDES US FAERS | |
| 24 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | FAERS: 1 | US FAERS | |
| 25 | Amlodipine | FAERS: 1 | US FAERS | |
| 26 | Arthrotec | FAERS: 1 | US FAERS | |
| 27 | Asenapine | FAERS: 1 | US FAERS | |
| 28 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 29 | Buprenorphine | FAERS: 1 | US FAERS | |
| 30 | Celecoxib | FAERS: 1 | US FAERS | |
| 31 | Cinacalcet | FAERS: 1 | US FAERS | |
| 32 | Diclofenac | FAERS: 1 | US FAERS | |
| 33 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 34 | Estradiol | FAERS: 1 | US FAERS | |
| 35 | Exenatide | FAERS: 1 | US FAERS | |
| 36 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 37 | Leuprolide | FAERS: 1 | US FAERS | |
| 38 | Lisinopril | FAERS: 1 | US FAERS | |
| 39 | MDV 3100 | FAERS: 1 | US FAERS | |
| 40 | Metoprolol | FAERS: 1 | US FAERS | |
| 41 | Naltrexone | FAERS: 1 | US FAERS | |
| 42 | Olanzapine | FAERS: 1 | US FAERS | |
| 43 | Oxymorphone | FAERS: 1 | US FAERS | |
| 44 | Prednisone | FAERS: 1 | US FAERS | |
| 45 | Pregabalin | FAERS: 1 | US FAERS | |
| 46 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 47 | Simvastatin | FAERS: 1 | US FAERS | |
| 48 | Tamsulosin | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 49 | Tamsulosin | FAERS: 1 | US FAERS | |
| 50 | Telmisartan | FAERS: 1 | US FAERS | |
| 51 | Vardenafil Dihydrochloride | FAERS: 1 | US FAERS | |
| 52 | Varenicline | FAERS: 1 | US FAERS | |
| 53 | Venlafaxine Hydrochloride | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 54 | Zolpidem | FAERS: 1 | US FAERS | |
| 55 | alfuzosin | FAERS: 1 | US FAERS | |
| 56 | candesartan cilexetil | FAERS: 1 | US FAERS | |
| 57 | desloratadine | FAERS: 1 | US FAERS | |
| 58 | gadodiamide | FAERS: 1 | US FAERS | |
| 59 | ziprasidone | FAERS: 1 | SIDER US FAERS | |
| 60 | Atomoxetine Hydrochloride | OFFSIDES | ||
| 61 | Chlorpromazine | OFFSIDES | ||
| 62 | Desvenlafaxine Succinate | OFFSIDES | ||
| 63 | Lamotrigine | OFFSIDES | ||
| 64 | Paliperidone Palmitate | Canada Vigilance: 1 | Canada Vigilance | |
| 65 | Theophylline | OFFSIDES | ||
| 66 | Tiagabine | OFFSIDES | ||
| 67 | rofecoxib | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.